Blidner, Ada G.
Choi, Jennifer
Cooksley, Tim
Dougan, Michael
Glezerman, Ilya
Ginex, Pamela
Girotra, Monica
Gupta, Dipti
Johnson, Douglas
Shannon, Vickie R.
Suarez-Almazor, Maria
Rapoport, Bernardo L. http://orcid.org/0000-0001-7610-3653
Anderson, Ronald
Article History
Received: 21 April 2020
Accepted: 20 August 2020
First Online: 28 August 2020
Compliance with ethical standards
:
: AB, RA, JC, TC, PG, DG, and VRS have no conflict of interest to declare. MC reports grants from Novartis, other from Neoleukin Therapeutics, personal fees from Partner Therapeutics, personal fees from Tillotts Pharma, and grants from Genentech, outside the submitted work. MG reports other from Bristol Myers Squibb (BMS) and other from AstraZeneca, outside the submitted work. IG reports other from Pfizer Inc and personal fees from CytomX Inc, outside the submitted work. DBJ reports other from Array Biopharma, grants and other from BMS, grants from Incyte, other from Jansen, other from Merck, and other from Novartis, outside the submitted work. In addition, DBJ has a patent co-inventor on use of CTLA-4 agonist for IAEs pending. BLR reports personal fees and other from Merck and Co, grants, personal fees, and other from BMS; grants, personal fee,s and other from Roche South Africa; and personal fees and other from AstraZeneca, during the conduct of the study. MSA reports personal fees from Gilead, grants from Pfizer, and personal fees from Abbvie, outside the submitted work. All work with these entities has ended.